Is Danggui Safe to be Taken by Breast Cancer Patients?—A Skepticism Finally Answered by Comprehensive Preclinical Evidence

Angelica sinensis (AS, Danggui) has long been regarded to stimulate breast cancer growth; hence, the use of AS in breast cancer patients remains a major concern for both patients and practitioners. Since safety studies of herbs would be unethical to carry out in patients, the present study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yue, Grace Gar-Lee, Wong, Lok-Sze, Leung, Hoi-Wing, Gao, Si, Tsang, Julia Yuen-Shan, Lin, Zhi-Xiu, Law, Bonita Ka-Bo, Tse, Gary Man-Kit, Lau, Clara Bik-San
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604035/
https://www.ncbi.nlm.nih.gov/pubmed/31293425
http://dx.doi.org/10.3389/fphar.2019.00706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604035/
https://www.ncbi.nlm.nih.gov/pubmed/31293425
http://dx.doi.org/10.3389/fphar.2019.00706

Ejemplares similares